Title:
FURO-PYRIDONE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/088493
Kind Code:
A1
Abstract:
The present application provides a furo-pyridone compound and a use thereof. The furo-pyridone compound provided in the present application can selectively inhibit the combination of a BET family bromodomain and acetylated lysine, can be used as a bromodomain inhibitor, and is used for treating BET related diseases such as cancer and inflammation.
Inventors:
XU YONG (CN)
LI JUNHUA (CN)
ZHANG YAN (CN)
ZHANG CHENG (CN)
ZHUANG XIAOXI (CN)
LI JUNHUA (CN)
ZHANG YAN (CN)
ZHANG CHENG (CN)
ZHUANG XIAOXI (CN)
Application Number:
PCT/CN2022/142283
Publication Date:
May 25, 2023
Filing Date:
December 27, 2022
Export Citation:
Assignee:
GUANGZHOU INST BIOMED & HEALTH (CN)
International Classes:
C07D213/64; A61K31/472; A61K31/506; C07D491/048; C07D495/04
Domestic Patent References:
| WO2021222466A1 | 2021-11-04 |
Foreign References:
| CN105189515A | 2015-12-23 | |||
| CN113226322A | 2021-08-06 | |||
| US20210002293A1 | 2021-01-07 |
Attorney, Agent or Firm:
BEYOND ATTORNEYS AT LAW (CN)
Download PDF: